FATE - CIK 0001434316
FATE THERAPEUTICS INC (FATE) reported net income of -$136.31M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$136.31M | +26.8% |
| FY 2024 | -$186.26M | -15.7% |
| FY 2023 | -$160.93M | +42.9% |
| FY 2022 | -$281.72M | -32.8% |
| FY 2021 | -$212.15M | -22.4% |
| FY 2020 | -$173.39M | -76.7% |
| FY 2019 | -$98.15M | -47.4% |
| FY 2018 | -$66.60M | -55.1% |
| FY 2017 |
FATE THERAPEUTICS INC (FATE) reported net income of -$136.31M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, FATE THERAPEUTICS INC's net income declined from -$13.43M to -$136.31M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$42.95M |
| -28.4% |
| FY 2016 | -$33.46M | -11.6% |
| FY 2015 | -$29.99M | -15.9% |
| FY 2014 | -$25.88M | -23.9% |
| FY 2013 | -$20.89M | -46.7% |
| FY 2012 | -$14.24M | -6.0% |
| FY 2011 | -$13.43M | - |